Clinical Trials
9
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
The Vitality Mammography Messaging Study
- Conditions
- Breast Cancer Female
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 7655
- Registration Number
- NCT06277141
- Locations
- 🇿🇦
University of Witwatersrand, Johannesburg, Gauteng, South Africa
Testing the Effectiveness of Different Messaging Approaches to Increase Doctor Visits Amongst Individuals With Risk Factors for Diabetes
- Conditions
- Pre-diabetesType 2 Diabetes
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 5000
- Registration Number
- NCT05755555
- Locations
- 🇿🇦
Discovery Vitality, Johannesburg, Gauteng, South Africa
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
- Conditions
- SARS CoV 2 Infection
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 500000
- Registration Number
- NCT05148845
- Locations
- 🇿🇦
Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern Cape, South Africa
🇿🇦PHOENIX Pharma Pty Ltd, Port Elizabeth, Eastern Cape, South Africa
🇿🇦Josha Research, Bloemfontein, Free State, South Africa
Sisonke (Together): OPEN LABEL TRIAL COVID-19
- Conditions
- SARS (Severe Acute Respiratory Syndrome)
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 477102
- Registration Number
- NCT04838795
- Locations
- 🇿🇦
Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern Cape, South Africa
🇿🇦PHOENIX Pharma Pty Ltd, Port Elizabeth, Eastern Cape, South Africa
🇿🇦Josha Research, Bloemfontein, Free State, South Africa
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
- First Posted Date
- 2020-10-09
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Wits Health Consortium (Pty) Ltd
- Target Recruit Count
- 74
- Registration Number
- NCT04581915
- Locations
- 🇿🇦
The Perinatal HIV Research Unit - Matlosana, Klerksdorp, North West Province, South Africa
- Prev
- 1
- 2
- Next